Dragos G.

Dragos G. has extensive experience in the field of biophysical methods and gene therapy formulation development, with a focus on chromatographic methods for protein and antibody analysis. Dragos has held various scientific positions at companies such as Kate Therapeutics, PhenoTarget Biosciences, and Locanabio. Prior to their industry roles, Dragos worked as a postdoc at The Scripps Research Institute, focusing on enantioselective processes and origins of life research. Dragos holds a PhD from Aix-Marseille University and a Micro-MBA from the University of California, San Diego.